Citadel Advisors’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $141K | Sell |
|
|||||
|
2025
Q1 | $164K | Sell |
|
|||||
|
2024
Q4 | $1.71M | Buy |
|
|||||
|
2024
Q3 | $259K | Buy |
|
|||||
|
2024
Q2 | $115K | Sell |
|
|||||
|
2024
Q1 | $710K | Sell |
|
|||||
|
2023
Q4 | $679K | Buy |
|
|||||
|
2023
Q3 | $563K | Sell |
|
|||||
|
2023
Q2 | $811K | Sell |
|
|||||
|
2023
Q1 | $4.55M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $297K | Sell |
|
|||||
|
2022
Q2 | $577K | Buy |
|
|||||
|
2022
Q1 | $402K | Sell |
|
|||||
|
2021
Q4 | $729K | Buy |
|
|||||
|
2021
Q3 | $1.09M | Sell |
|
|||||
|
2021
Q2 | $2.92M | Sell |
|
|||||
|
2021
Q1 | $4.76M | Sell |
|
|||||
|
2020
Q4 | $5.21M | Buy |
|
|||||
|
2020
Q3 | $6.34M | Buy |
|